IL17A and psoriasis: However, total skin gene expression profiling is confronting limitations to dissect the IL-23/T17 autoimmune axis for explaining recent clinical trial findings (1): systemic administration of an anti-IL-17A monoclonal antibody increased the expression of genes involved in skin homeostasis promotion and KC stem cell activation in psoriasis skin (10).